There has been fear that decades of enmity between the two could spill over into all-out war
Russia’s sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against Covid-19, according to a statement on the Sputnik V Twitter account on Friday.
Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.
Phase II-III trials are ongoing in India, the statement said. Drugmaker Dr Reddy’s Laboratories Ltd has said it expects late-stage trials to be completed by as early as March 2021.
There has been fear that decades of enmity between the two could spill over into all-out war
The leading hypermarket chain has implemented additional measures to ensure sufficient stock availability for shoppers
Thousands of personnel deployed to clear accumulated water, clogged drains, and fallen trees
Areas such as Abu Shagara, Al Qasimiya, King Faisal Road, Al Mahatta, and Majaz have been particularly affected
The Ministry of Foreign Affairs reiterated its call on the United Nations and the UN Security Council to fulfill their responsibilities
This step aims bring relief to thousands of residents in Emaar’s communities who have been badly affected by unprecedented rains
Dressed in all black, the man was seen directing traffic for nearly six hours
Four others to drive away a luxury vehicle each